NFKB1 and early-onset autosomal dominant Alzheimer disease: Neuroinflammation, driven by microglial activation and excessive pro-inflammatory cytokine release, is a key contributor to Alzheimer’s disease (AD) pathology, with the NF-κB signaling pathway playing a central role in sustaining chronic inflammation.